HK1101354A1 - Levocetirizine hydrochloride formulation for external use - Google Patents

Levocetirizine hydrochloride formulation for external use

Info

Publication number
HK1101354A1
HK1101354A1 HK07109304.5A HK07109304A HK1101354A1 HK 1101354 A1 HK1101354 A1 HK 1101354A1 HK 07109304 A HK07109304 A HK 07109304A HK 1101354 A1 HK1101354 A1 HK 1101354A1
Authority
HK
Hong Kong
Prior art keywords
external use
hydrochloride formulation
levocetirizine hydrochloride
levocetirizine
formulation
Prior art date
Application number
HK07109304.5A
Inventor
Zhiquan Zhao
Original Assignee
Lunan Pharm Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunan Pharm Group Corp filed Critical Lunan Pharm Group Corp
Publication of HK1101354A1 publication Critical patent/HK1101354A1/en

Links

HK07109304.5A 2005-11-29 2007-08-27 Levocetirizine hydrochloride formulation for external use HK1101354A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510129203 CN1813743A (en) 2005-11-29 2005-11-29 External-use formulation of levocetirizine hydrochloride

Publications (1)

Publication Number Publication Date
HK1101354A1 true HK1101354A1 (en) 2007-10-18

Family

ID=36906177

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109304.5A HK1101354A1 (en) 2005-11-29 2007-08-27 Levocetirizine hydrochloride formulation for external use

Country Status (2)

Country Link
CN (1) CN1813743A (en)
HK (1) HK1101354A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120142704A1 (en) * 2009-08-12 2012-06-07 Lun Better Pharmaceutical Co., Ltd Pharmaceutical solution of cetirizine hydrochloride
CN103860462A (en) * 2014-01-14 2014-06-18 万特制药(海南)有限公司 Levocetirizine hydrochloride syrup and preparation method
WO2022175829A1 (en) 2021-02-17 2022-08-25 Cellix Bio Private Limited Topical formulations and compositions

Also Published As

Publication number Publication date
CN1813743A (en) 2006-08-09

Similar Documents

Publication Publication Date Title
ZA200801773B (en) New formulation
TWI370115B (en) New formulation
HK1198914A1 (en) Novel dosage formulation
PT3424932T (en) Boronophthalides for therapeutic use
IL191287A0 (en) Atorvastatin formulation
IL189781A0 (en) Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same
GB0526419D0 (en) Formulation
IL187510A0 (en) Proteases for pharmaceutical use
GB0517673D0 (en) Formulation
EP1928469A4 (en) Fulvestrant formulation
EP1852106A4 (en) Solid ophthalmic drug for external use
EP1938808A4 (en) Preparation for external use
GB0423565D0 (en) Formulation
PL1855661T3 (en) Formulation for aviptadil
GB0412530D0 (en) Formulation
GB0501030D0 (en) Formulation
HK1101354A1 (en) Levocetirizine hydrochloride formulation for external use
GB0504940D0 (en) Vaccine formulation
PL1688129T3 (en) New therapeutic formulation
ZA200710642B (en) Proteases for pharmaceutical use
GB0522473D0 (en) A pharmaceutical formulation
PT1855661E (en) Formulation for aviptadil
GB0506035D0 (en) Improved formulation
GB0515937D0 (en) Pharmaceutical formulation
GB0500807D0 (en) Formulation